PD16-02 ULTRASTRUCTURAL FINDINGS OF COVID-19 INFECTION IN THE PROSTATE

Abstract

You have accessJournal of UrologyCME1 May 2022PD16-02 ULTRASTRUCTURAL FINDINGS OF COVID-19 INFECTION IN THE PROSTATE Rohit Reddy, Eliyahu Kresch, Natoli Farber, Parris Diaz, and Ranjith Ramasamy Rohit ReddyRohit Reddy More articles by this author , Eliyahu KreschEliyahu Kresch More articles by this author , Natoli FarberNatoli Farber More articles by this author , Parris DiazParris Diaz More articles by this author , and Ranjith RamasamyRanjith Ramasamy More articles by this author View All Author Informationhttps://doi.org/10.1097/JU.0000000000002548.02AboutPDF ToolsAdd to favoritesDownload CitationsTrack CitationsPermissionsReprints ShareFacebookLinked InTwitterEmail Abstract INTRODUCTION AND OBJECTIVE: SARS-CoV-2 utilizes two integral membrane proteins ACE2 and TMPRSS2 for viral replication. It has been established TMPRS22 specifically is found in high concentrations throughout the prostate found to be linked to prostatic disease progression. This project examined the histopathological, ultrastructural, and immunofluorescent elements of prostatic tissue from men infected by SARS-CoV-2. METHODS: We evaluated prostate tissue in men with worsening lower urinary tract symptoms who underwent HoLEP procedure after SARS-CoV-2 infection. Biopsied tissue was visualized by transmission electron microscopy (TEM), immunofluorescence, and viral presence was confirmed by quantitative polymerase chain reaction (RT-PCR). RESULTS: Multiple coronavirus-like spiked viral particles ranging from 73.3mm to 109mm were visualized by TEM (Figure). Histochemical and immunofluorescence concurrently showed presence of distinct hyalinization, fibrosis, and presence of spike protein (Figure 2). RT-PCR confirmed the identity of the viral bodies as SARS-CoV-2 (Figure 3). CONCLUSIONS: This study provides evidence that SARS-CoV-2 not only enters prostatic tissue but may persist beyond initial infection period. In addition to establishing the persistence of SARS-CoV-2 particles in prostatic tissue, this report suggests the importance of discerning the relationships between COVID-19, lower urinary tract symptom severity, and prostatic hyperplasia. 2 Source of Funding: This work was supported by National Institutes of Health Grant R01 DK130991 and Clinician Scientist Development Grant from the American Cancer Society to RR © 2022 by American Urological Association Education and Research, Inc.FiguresReferencesRelatedDetails Volume 207Issue Supplement 5May 2022Page: e269 Advertisement Copyright & Permissions© 2022 by American Urological Association Education and Research, Inc.MetricsAuthor Information Rohit Reddy More articles by this author Eliyahu Kresch More articles by this author Natoli Farber More articles by this author Parris Diaz More articles by this author Ranjith Ramasamy More articles by this author Expand All Advertisement PDF DownloadLoading ...